• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M
Ethereum developers have implemented the Dencun hard fork in the Goerli test network

Ethereum developers have implemented the Dencun hard fork in the Goerli test network

user avatar

by Max Nevskyi

2 years ago


The core team of Ethereum has successfully activated the Dencun (Cancun-Deneb) upgrade in the Goerli test network, implementing EIP-4844. However, the hard fork completion plan was not executed on schedule.

This upgrade includes the Proto-Danksharding option, designed to scale the network by introducing a new type of transaction for handling large binary data arrays (BLOB). It is expected to reduce transaction fee costs for L2 solutions based on Rollup technology.

The lead developer, Tim Beiko, noted that "BLOB objects are coming in," although most of them turned out to be empty.

The full completion of the upgrade was unsuccessful, likely due to about a fifth of client operators not updating their software (there were several of them).

It appears we've had a chain split! Client teams are investigating, but it may take some time to identify and address the issues. Stay tuned for updates!wrote Beiko.

According to his estimate, completing the work may take several days.

According to the preliminary schedule, the deployment of the Dencun upgrade in the Sepolia test network is planned for January 30th, and on February 7th, it is scheduled for the Holesky network. It is expected that by the end of February, the team plans to conduct a hard fork in the main network.

The construction of the initially planned upgrade for the fourth quarter of 2023 was postponed by developers due to ongoing consensus issues.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.